CD79A and autoimmune thyroid disease: The GSEA result demonstrated a higher enrichment of genes in immune-signaling pathways, including allograft rejection, antigen processing and presentation, autoimmune thyroid disease, the intestinal immune network for IgA production, primary immunodeficiency, and Th1 and Th2 cell differentiation.